09.13.25 -- Cell & Gene Best Of August

Discover how allogeneic NK cell therapies are reshaping cancer immunotherapy! Join Cell & Gene's Erin Harris as she hosts industry leaders for a dynamic discussion on their groundbreaking, complementary approaches. Don’t miss this inside look at the future of cell therapy—Register now for free! This event is supported by ThermoFisher Scientific.

Cell & Gene Chief Editor Erin Harris shared a timely discussion on the latest advancements and opportunities in the rapidly evolving field of exosomes and EVs within cell and gene therapy.

Pharmaceutical firms are increasingly turning to ERP systems to modernize operations. These platforms unify core functions, including supply chain management, manufacturing, and financial analysis.

Without contract manufacturers, small biotechs often don't stand a chance of reaching commercial production scales, let alone global access for their drugs.

This conversation explores the current and future state of hepatology clinical trials, offering timely perspectives for those looking to navigate this evolving clinical trial landscape.

The incorporation of smartphones and wearable devices in clinical trials provide a unique opportunity to monitor behavior in a non-invasive manner. Learn more in this detailed study.

By fostering a culture of continuous improvement through internal audits, clinical research sites can identify non-compliance issues and enhance their research practices.